LIOM
LIOM is developing wearable sensing technology for non-invasive biochemical monitoring, beginning with glucose. Formerly called Spiden, the company is working toward continuous measurements through the skin; its platform remains a development effort rather than an established consumer diagnostic.
2026-09-14
Allez Health
Allez Health develops wearable biosensor technology for continuous metabolic monitoring. Its investigational platform includes glucose and lactate sensing, with a focus on connected measurements that can support diabetes management and research into metabolic health.
2026-09-14
Biolinq
Biolinq develops wearable biosensors that measure glucose through small sensing elements placed within the skin. Its platform focuses on metabolic monitoring and combines biochemical measurements with contextual health information to help users understand changes over time.
2026-09-14
Orange Biomed
Orange Biomed is developing portable A1C testing based on microfluidic single-cell analysis. Its approach examines blood cells in a small sample to support diabetes monitoring, with a reusable reader and disposable test components intended for point-of-care use.
2026-09-14
Automated Microfluidic System for Point-of-Care Detection of Pathogens
A new microfluidic platform turns complex pathogen testing into a portable glucose-meter readout.
2026-05-12
Organ-on-a-chip technology replicates decades of human aging in just four days
A Berkeley organ-on-a-chip uses human serum to mimic decades of metabolic aging in just four days.
2026-04-20